This convenient, point-of-care (POC), handheld device analyzes a finger prick sample of blood for creatinine levels—an important indicator of a patient’s renal function. The test can be performed in the imaging suite, with results available in as little as 30 seconds. Evaluating a patient’s kidney function can help determine their ability to safely receive IV contrast prior to CT and MR imaging—an important precaution especially for patients with risk factors such as diabetes, known kidney impairment, and advanced age. In addition, EZ Chem also features GFR result calculation and display.

October 2007


Additional Content

News | Contrast Media

Oct. 27, 2026 – Bracco has announced plans to invest $230 million to establish its first U.S. manufacturing facility for ...

Time October 28, 2026
arrow
News | Cardiac Imaging

Aug. 11, 2026 — Bracco Imaging recently announced that VueJect, its dedicated ultrasound contrast delivery system ...

Time August 12, 2026
arrow
News | Contrast Agents

June 15, 2026 – Bayer has announced that the U.S. Food and Drug Administration (FDA) approved Ambelvist (gadoquatrane) ...

Time June 16, 2026
arrow
News | FDA

May 18, 2026 — ACIST Medical Systems, a Bracco company, has received U.S. Food and Drug Administration (FDA) clearance ...

Time May 18, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

March 4, 2026 — The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to Bayer for the expanded ...

Time March 04, 2026
arrow
Subscribe Now